Epoch Pharmaceuticals, Inc.

Basic Information

1725 220TH ST SE, 104
Bothell, WA, 98052

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. LOW COST HIV DRUG RESISTANCE MONITORING

    Amount: $100,000.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  2. SELECTIVELY BINDING COMPLEMENTARY OLIGONUCLEOTIDES

    Amount: $100,000.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  3. ANTIBIOTIC SUSCEPTIBILITY TESTING FOR ORAL BACTERIA

    Amount: $97,762.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  4. RAPID AUTOMATED DNA PROBE DIAGNOSTIC TEST FOR MALARIA

    Amount: $98,952.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  5. DNA Probe Detection of Oral Spirochetes

    Amount: $98,307.00

    Treponema denticola is an oral spirochete associated with periodontal disease. T. denticola belongsfamily of oral spirochetes which, although found in low numbers in healthy tissue, increases in numbO ...

    SBIR Phase I 1995 Department of Health and Human Services
  6. Biochemistry of Oligomer/Pyrroloindole Conjugates

    Amount: $93,147.00

    We have developed the chemistry to conjugate a pyrroloindole tripeptide (CDPI3) analog of CC-1065 t3' ends of any oligodeoxyribonucleotide (ODN). The resultant conjugates hybridize sequence specificaD ...

    SBIR Phase I 1995 Department of Health and Human Services
  7. DNA PROBES TO DETECT PREDISPOSITION TO TYPE I DIABETES

    Amount: $470,000.00

    INSULIN-DEPENDENT DIABETES MELLITUS (TYPE I) OCCURS IN ABOUT 0.5% OF CAUCASIANS. THE INCIDENCE INCREASES OVER 20-FOLD IN INDIVIDUALS WITH THE SPEIFIC SUSCEPTIBILITY GENE HLA-DQ3.2. APPROXIMATELY 70% O ...

    SBIR Phase II 1994 Department of Health and Human Services
  8. Probes for Metabolic Markers Of Antibiotic Resistance

    Amount: $484,191.00

    The aim is to evaluate a novel technology for testing the susceptibility of prokaryotes to certain antibiotics. Our goal is to develop rapid antibiotic susceptibility tests for Mycobacterium tuberculo ...

    SBIR Phase II 1994 Department of Health and Human Services
  9. Probes for Metabolic Markers Of Antibiotic Resistance

    Amount: $48,220.00

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  10. NUCLEAR TARGETING OF OLIGONUCLEOTIDE-PEPTIDE CONJUGATES

    Amount: $499,629.00

    THIS PHASE I STUDY WILL EXPLORE THE THERAPEUTIC POSSIBILITIES OF ANTISENSE OLIGODEOXYNUCLEOTIDES THAT HAVE BEEN COVALENTLY CONJUGATED TO SIGNAL PEPTIDES THAT CAN DIRECT THE TRANSPORT OF PROTEINS INTO ...

    SBIR Phase II 1992 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government